Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | GBA1 | P04062 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.37 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29783272 | 1.00 | NR1H4 (0.47) | NR1H4KMT2ALMNAMAPTGAA | |
| SCHEMBL19027542 | 0.83 | KMT2A (0.51) | NR1H4KMT2ALMNAMAPTALDH1A1 | |
| SCHEMBL23036593 | 0.82 | TDP1 (0.42) | KMT2AMAPTHPGDALDH1A1HSD17B10 | |
| SCHEMBL23036104 | 0.81 | NR1H4 (0.40) | NR1H4KMT2ALMNAMAPTGAA | |
| SCHEMBL767555 | 0.81 | NR1H4 (0.55) | NR1H4KMT2ALMNAMAPTGBA1 | |
| SCHEMBL19621079 | 0.81 | KMT2A (0.58) | NR1H4KMT2ALMNAGAAHPGD | |
| SCHEMBL18985165 | 0.81 | LMNA (0.46) | NR1H4KMT2ALMNAMAPTGAA | |
| SCHEMBL767373 | 0.81 | NR1H4 (0.54) | NR1H4KMT2ALMNAMAPTALDH1A1 | |
| SCHEMBL19630948 | 0.80 | NR1H4 (0.54) | NR1H4KMT2ALMNAMAPTALDH1A1 | |
| SCHEMBL14339402 | 0.79 | NR1H4 (0.72) | NR1H4KMT2ALMNAMAPTGBA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3784751-B1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2024-08-07 | — | — | EP | disclosed |
| US-11312907-B2 | Liquid crystal mixture and liquid crystal display | MERCK PATENT GMBH (DE) | 2022-04-26 | — | — | US | disclosed |
| US-11312907-B2 | Liquid crystal mixture and liquid crystal display | MERCK PATENT GMBH (DE) | 2022-04-26 | — | — | US | disclosed |
| US-20220106525-A1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2022-04-07 | — | — | US | disclosed |
| EP-3864111-A1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | Merck Patent GmbH (DE) | 2021-08-18 | — | — | EP | disclosed |
| US-11053442-B2 | Liquid crystal mixture and liquid crystal display | MERCK PATENT GMBH (DE) | 2021-07-06 | — | — | US | disclosed |
| US-11053442-B2 | Liquid crystal mixture and liquid crystal display | MERCK PATENT GMBH (DE) | 2021-07-06 | — | — | US | disclosed |
| US-20210071081-A1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2021-03-11 | — | — | US | disclosed |
| US-20210071081-A1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2021-03-11 | — | — | US | disclosed |
| EP-3784751-A1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | Merck Patent GmbH (DE) | 2021-03-03 | — | — | EP | disclosed |
| US-20200255740-A1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2020-08-13 | — | — | US | disclosed |
| US-20200255740-A1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2020-08-13 | — | — | US | disclosed |
| EP-3390570-B1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2020-03-18 | — | — | EP | disclosed |
| EP-3390570-A1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | Merck Patent GmbH (DE) | 2018-10-24 | — | — | EP | disclosed |
| WO-2017102068-A1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2017-06-22 | — | — | WO | disclosed |
| WO-2017102068-A1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2017-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220106525-A1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | CXCR1, PYM1, F11 | NR1H4 1969/4885KMT2A 4249/4885LMNA 1207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.